Stay updated on ADMEC-O: Clinical Trial of Immunotherapy vs Observation
Sign up to get notified when there's something new on the ADMEC-O: Clinical Trial of Immunotherapy vs Observation page.

Latest updates to the ADMEC-O: Clinical Trial of Immunotherapy vs Observation page
- Check6 days agoChange DetectedA new revision label (v3.3.2) is shown, replacing the previous v3.3.1. No other content or data on the page appears to be altered.SummaryDifference0.0%

- Check13 days agoChange DetectedThe Publications section now notes that publications are automatically filled from PubMed and may not be about the study, and the page shows a revised version label: Revision: v3.3.1.SummaryDifference0.1%

- Check20 days agoChange DetectedThe government funding/operating status banner was removed from the page. This banner previously informed users about potential delays and NIH operations status, but its removal does not affect the trial details or eligibility criteria.SummaryDifference0.3%

- Check34 days agoChange DetectedNo significant changes to the study details were detected; the page continues to present the ADMEC-O trial with nivolumab vs observation, including its design, endpoints, and eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedUpdated to v3.2.0 with a government operating-status notice; a resource entry (Cutaneous neuroendocrine carcinoma) was removed and revision tag shows v3.1.0 previously.SummaryDifference3%

- Check70 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to ADMEC-O: Clinical Trial of Immunotherapy vs Observation
Enter your email address, and we'll notify you when there's something new on the ADMEC-O: Clinical Trial of Immunotherapy vs Observation page.